Replicating Lewy body formation in living neurons to understand Parkinson’s disease

FHS
October 8, 2024
11:19 pm

Lewy bodies are a hallmark of Parkinson’s disease (PD) and other related neurological conditions. Understanding why and how they develop is critical to developing better treatments.

Detailed data confirm benefits — and risks — of Eli Lilly’s Alzheimer’s drug

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval

July 17, 2023

Medicare Debuts Another Primary Care-Focused Accountable Care Model

Medicare is trying again with another accountable care organization (ACO) payment model aimed at primary care doctors, but reactions to the new model are mixed

March 27, 2024

Risk Adjusted Net Present Value: What is the current valuation of SpringWorks Therapeutics’s Mirdametinib

The revenue for Mirdametinib is expected to reach an annual total of $450 mn by 2034 in the US based off GlobalDatas Expiry Model. The

September 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.